Publication | Open Access

Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition

Neuro-oncologyNovel CyanothiouracilMedicineAdenosine Receptor BindingCyanothiocytosine DerivativesPharmacological AgentTumor TargetingAnti-cancer AgentRadiation OncologyPharmacologyGliomaDrug Discovery